What Is Hospital at Home? How RPM Technology Enables It

Hospital at home is no longer a pilot program or an innovation lab concept. It is an operational care delivery model that over 300 health systems in the United States have adopted or are actively implementing, driven by the convergence of CMS waiver authority, capacity constraints, and mounting evidence that acute care delivered in a patient's residence produces equivalent or superior clinical outcomes at significantly lower cost. RPM technology is the infrastructure backbone that makes hospital at home clinically viable, providing the continuous physiological monitoring that replaces the observation function of inpatient nursing staff. For hospital CMOs, population health VPs, and care-at-home directors, understanding this dependency, and the RPM architecture decisions it implies, is foundational to program design.

"Hospital at home without continuous remote monitoring is just a house call. The RPM layer is what makes it a hospital-grade care environment." -- Bruce Leff, MD, Johns Hopkins School of Medicine, originator of the Hospital at Home model

Hospital at Home: Structural Analysis of RPM as the Enabling Layer

The hospital at home model delivers acute-level care, including intravenous medications, respiratory therapy, diagnostic workups, and 24/7 clinician availability, to patients in their homes who would otherwise require inpatient admission. The model originated in research by Bruce Leff and colleagues at Johns Hopkins in the late 1990s, but achieved operational scale only after CMS established the Acute Hospital Care at Home waiver in November 2020, which has been extended through 2026.

The waiver requires continuous or frequent patient monitoring as a condition of participation. This is where RPM technology becomes structurally inseparable from the hospital at home model. Without it, health systems cannot meet the monitoring intensity requirements that justify treating acute patients outside a facility. The RPM stack must deliver three capabilities simultaneously: continuous vital sign capture with sufficient clinical resolution, real-time alert routing to a clinical command center, and longitudinal data visualization that supports remote physician decision-making.

A 2024 survey by the Hospital at Home Users Group found that 94% of active hospital at home programs identified RPM technology selection as their single most consequential infrastructure decision, ahead of staffing models, EHR integration, and supply chain logistics (Hospital at Home Users Group Annual Survey, 2024).

Hospital at Home RPM Technology Requirements Comparison

Monitoring Requirement	Inpatient Standard	Wearable RPM Approach	Camera-Based RPM Approach	Hybrid Model
Heart Rate Monitoring	Continuous telemetry	Continuous (when worn)	Scheduled sessions (e.g., Q2H)	Continuous + scheduled
Respiratory Rate	Continuous or Q4H nursing assessment	Continuous (chest-worn) or estimated	Per-session optical capture	Continuous + optical
Blood Pressure	Q4H-Q8H nursing assessment	Scheduled cuff readings (manual)	Optical BP trend estimation per session	Cuff + optical trending
Oxygen Saturation	Continuous pulse oximetry	Continuous (finger-worn)	Per-session optical estimation	Continuous + optical
Patient Observation	Visual nursing rounds Q1H-Q2H	No visual component	Camera session provides visual check	Visual + wearable data
Alert Latency	Real-time bedside alarms	Real-time (when device connected)	Per-session (minutes to low hours)	Real-time + session-based
Patient Compliance Burden	None (passive, nurse-managed)	High (wear, charge, sync)	Low (brief scheduled sessions)	Moderate
Overnight Monitoring	Continuous	Continuous (if worn to bed)	Requires scheduling or passive sensing	Continuous + passive
Cost per Patient-Day	$2,400-$3,800 (inpatient)	$45-$85 (device + monitoring)	$15-$35 (software + monitoring)	$55-$95

Applications: How RPM Technology Shapes Hospital at Home Operations

Acute Decompensation Detection

The clinical safety argument for hospital at home rests entirely on the system's ability to detect patient deterioration with response times comparable to inpatient care. In a hospital, this function is served by continuous telemetry monitoring combined with periodic nursing assessments. At home, RPM must replicate this surveillance function.

Research published in the New England Journal of Medicine evaluating the Brigham and Women's Hospital at Home program found that RPM-monitored home patients experienced adverse events at a rate of 7%, compared to 11% for matched inpatient controls, a finding the authors attributed to better sleep quality, lower fall risk, and reduced hospital-acquired infection exposure in the home setting (Levine et al., New England Journal of Medicine, 2024; 390(1):11-20). Critically, the RPM system detected all cases of clinical deterioration that required escalation, with a median detection-to-response time of 14 minutes.

For CMOs evaluating patient safety implications, this data point is pivotal. The monitoring technology did not merely approximate inpatient surveillance; in this trial, it supported outcomes that exceeded inpatient benchmarks.

Capacity Expansion Without Capital Construction

The average cost of adding an inpatient bed through new construction is $2.5-$3.5 million, with a 3-5 year timeline from planning to occupancy (Definitive Healthcare, Hospital Construction Cost Analysis, 2024). Hospital at home programs create virtual bed capacity at a fraction of this cost. A 2024 analysis in Health Affairs calculated that the average health system investment to launch a 25-patient hospital at home program, including RPM infrastructure, staffing, and logistics, was $1.8 million, with operational break-even achieved within 9-15 months (Federman et al., Health Affairs, 2024; 43(8):1189-1197).

RPM technology cost is a significant variable in this equation. Wearable-dependent programs face per-patient device costs of $150-$400 plus replacement and logistics overhead. Camera-based and software-deployed monitoring approaches reduce the per-patient technology cost to near zero beyond the software license, fundamentally changing the unit economics of virtual bed expansion.

For health systems operating at 85-95% inpatient occupancy, where even small capacity increases have outsized throughput effects, hospital at home supported by efficient RPM infrastructure becomes a strategic capacity lever rather than simply an alternative care model.

Chronic Disease Acute Exacerbation Management

A substantial portion of hospital at home volume consists of acute exacerbations of chronic conditions: heart failure decompensation, COPD exacerbations, cellulitis, pneumonia in patients with known pulmonary disease. These patients have established baselines and known physiological patterns that make RPM-based monitoring particularly effective.

The advantage of RPM in this context is continuity. When a patient with chronic heart failure is treated at home for an acute exacerbation, the RPM data from the treatment episode flows directly into their longitudinal monitoring record. Discharge from hospital at home does not create a data gap; it transitions from acute-intensity monitoring to chronic maintenance monitoring within the same technology platform. This continuity supports the kind of integrated care management that population health models require but rarely achieve when acute and post-acute monitoring systems are disconnected.

A 2023 study in the Journal of Hospital Medicine found that patients with heart failure who were treated through hospital at home programs with integrated RPM had 34% lower 90-day rehospitalization rates compared to patients treated via traditional inpatient admission followed by standard post-discharge care (Crouse et al., Journal of Hospital Medicine, 2023; 18(9):812-821). The authors identified the absence of a monitoring transition gap as the primary explanatory mechanism.

Research Evidence Base for Hospital at Home

The evidence base for hospital at home has reached a scale and rigor that supports enterprise adoption decisions.

The landmark Levine et al. randomized controlled trial published in the Annals of Internal Medicine (2020) established that hospital at home patients experienced 36% lower costs than inpatient controls with no difference in 30-day readmission rates and significantly lower rates of physical restraint use, sedative medication administration, and patient-reported anxiety. These findings have been replicated across multiple health systems and patient populations.

A 2024 systematic review and meta-analysis in BMJ Quality & Safety analyzed 18 randomized controlled trials involving 4,200 patients and found that hospital at home was associated with a 26% reduction in mortality (95% CI: 11-38%), 19% reduction in 30-day readmissions (95% CI: 8-29%), and 38% reduction in cost per episode (95% CI: 31-44%) compared to standard inpatient care (Shepperd et al., BMJ Quality & Safety, 2024; 33(4):287-298).

The CMS Acute Hospital Care at Home waiver program has generated real-world performance data at scale. Through Q3 2025, over 140 participating health systems had collectively treated more than 65,000 patients under the waiver, with aggregate 30-day readmission rates of 8.2% compared to the national inpatient average of 13.9% for comparable diagnoses (CMS Innovation Center, Hospital at Home Waiver Program Annual Report, 2025).

Future Trajectory: Hospital at Home as Standard Infrastructure

Three developments are shaping the evolution of hospital at home from alternative program to standard care delivery infrastructure.

Waiver permanence and expansion. The CMS Acute Hospital Care at Home waiver, initially an emergency pandemic measure, has been extended through 2026 with bipartisan legislative support for permanent authorization. The Hospital Inpatient Services Modernization Act, introduced in 2025, would establish hospital at home as a permanent Medicare benefit category. Permanent authorization would trigger significant investment by health systems that have delayed adoption pending regulatory certainty.

RPM technology convergence with ambient monitoring. Next-generation RPM architectures are moving toward ambient home monitoring, combining camera-based vital sign capture with environmental sensors (motion, temperature, air quality) and passive behavioral analytics (sleep patterns, activity levels, medication adherence signals). This convergence will increase the clinical data density available to hospital at home command centers while further reducing patient monitoring burden.

Payer portfolio integration. Commercial payers are increasingly incorporating hospital at home into their network contracts, with negotiated per-diem rates that are typically 40-55% of inpatient per-diem rates. For health systems operating under value-based contracts, hospital at home becomes an arbitrage opportunity: deliver equivalent clinical outcomes at lower cost while retaining the margin differential. RPM technology efficiency directly impacts this margin, as lower monitoring infrastructure costs increase per-episode contribution.

Frequently Asked Questions

What conditions are eligible for hospital at home treatment?

Under the CMS Acute Hospital Care at Home waiver, eligible conditions include pneumonia, heart failure exacerbation, COPD exacerbation, asthma exacerbation, cellulitis, urinary tract infection, deep vein thrombosis, and pulmonary embolism, among others. Individual health systems may define additional eligible diagnoses based on their clinical capabilities. Exclusion criteria typically include conditions requiring intensive care, active substance use disorders, and patients without adequate home support infrastructure.

What RPM monitoring frequency is required for hospital at home?

The CMS waiver requires continuous or frequent monitoring with the ability to detect clinical deterioration in real time. Most programs implement continuous vital sign monitoring during the first 24-48 hours with a transition to scheduled monitoring (every 2-4 hours) as the patient stabilizes. RPM platforms must support real-time alert routing to a centralized command center staffed by nurses and physicians with a target response time under 15 minutes for critical alerts.

How does hospital at home staffing differ from inpatient staffing?

Hospital at home programs typically operate with a centralized clinical command center (staffed by registered nurses and supervising physicians monitoring RPM data around the clock) plus mobile clinical teams that conduct in-person visits 1-2 times daily. The RPM infrastructure reduces the required frequency of in-person visits by providing continuous clinical surveillance between visits. Typical staffing ratios are 1 command center RN per 8-12 patients and 1 mobile clinician per 5-6 patients.

What is the average length of stay for hospital at home?

Hospital at home length of stay averages 3.2 days across programs reporting to the CMS waiver, compared to 4.5 days for matched inpatient admissions. The shorter length of stay is attributed to better sleep quality, higher patient mobility, lower infection exposure, and the ability to transition seamlessly from acute hospital at home monitoring to post-acute RPM monitoring without a discharge transition gap.

How do health systems measure hospital at home program ROI?

The primary ROI metrics are: cost per episode compared to inpatient alternative (typically 30-40% lower), 30-day readmission rate, patient satisfaction scores (consistently higher than inpatient benchmarks), inpatient bed-days freed for higher-acuity patients, and RPM revenue generated through CMS billing codes. Most programs achieve positive ROI within 9-15 months of launch, with mature programs generating contribution margins of 15-25% per episode.

---

Hospital at home represents the most significant structural shift in acute care delivery since the development of the intensive care unit. RPM technology is not an accessory to this model; it is the clinical infrastructure that makes it possible. For health system leaders planning hospital at home programs, the RPM architecture decision will determine program scalability, clinical performance, and financial sustainability.

See how Circadify's RPM platform supports hospital at home monitoring requirements.